Liquidia Corp (LQDA)
Every FINRA and SEC series the site collects for Liquidia Corp: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
11.9M
Short interest
settlement 2026-08-14
6.5
Days to cover
-0.9% vs prior
72.5%
Short share of volume
2026-09-11
57
Fails to deliver
settlement 2026-08-12
-$53.1M
Insider flow, 90 days
0 buys, 22 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in LQDA is 11,856,100 shares, down 477,007 shares over the last month. Over the last 48 readings it ranged from 9,947,656 shares (30 April 2026) to 22,399,615 shares (15 July 2025). At the reported average volume of 1.8M shares a day that is 6.5 days to cover, elevated.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/lqda" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 11,856,100 | -0.9% | 1,838,095 | 6.45 |
| 2026-07-31 | 11,962,898 | -3.0% | 1,449,810 | 8.25 |
| 2026-07-15 | 12,333,107 | -6.4% | 1,343,837 | 9.18 |
| 2026-06-30 | 13,179,590 | +13.5% | 3,251,301 | 4.05 |
| 2026-06-15 | 11,611,106 | +16.6% | 2,275,741 | 5.10 |
| 2026-05-29 | 9,955,978 | -2.5% | 1,281,423 | 7.77 |
| 2026-05-15 | 10,207,658 | +2.6% | 2,068,293 | 4.94 |
| 2026-04-30 | 9,947,656 | -12.9% | 1,016,024 | 9.79 |
| 2026-04-15 | 11,415,093 | -3.8% | 1,010,838 | 11.29 |
| 2026-03-31 | 11,861,739 | -3.2% | 1,024,935 | 11.57 |
| 2026-03-13 | 12,248,512 | +2.7% | 1,707,804 | 7.17 |
| 2026-02-27 | 11,927,074 | +0.8% | 2,314,372 | 5.15 |
| 2026-02-13 | 11,831,299 | -7.4% | 1,364,483 | 8.67 |
| 2026-01-30 | 12,782,206 | +0.8% | 2,018,686 | 6.33 |
| 2026-01-15 | 12,685,675 | +18.4% | 2,683,572 | 4.73 |
| 2025-12-31 | 10,709,682 | -18.1% | 924,707 | 11.58 |
| 2025-12-15 | 13,078,126 | -7.1% | 1,233,487 | 10.60 |
| 2025-11-28 | 14,080,117 | -12.7% | 2,108,161 | 6.68 |
| 2025-11-14 | 16,124,384 | -8.1% | 2,991,447 | 5.39 |
| 2025-10-31 | 17,552,798 | -1.5% | 2,151,008 | 8.16 |
| 2025-10-15 | 17,817,424 | -3.1% | 2,195,609 | 8.12 |
| 2025-09-30 | 18,386,736 | -0.4% | 3,399,798 | 5.41 |
| 2025-09-15 | 18,467,137 | +7.9% | 2,291,896 | 8.06 |
| 2025-08-29 | 17,116,552 | -6.9% | 2,274,986 | 7.52 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of LQDA volume is 72.5%, up 5.8 points over the last five sessions. Over the last 52 readings it ranged from 42.8% (14 August 2026) to 80.9% (26 August 2026). The latest reading is 6.9 points above the 30-session average of 65.6%, on 301K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 218K | 301K | 72.5% | 7,502 |
| 2026-09-10 | 230K | 372K | 61.7% | 8,285 |
| 2026-09-09 | 219K | 378K | 57.9% | 1,300 |
| 2026-09-08 | 264K | 434K | 60.9% | 2,200 |
| 2026-09-04 | 227K | 322K | 70.5% | 2,210 |
| 2026-09-03 | 256K | 383K | 66.7% | 900 |
| 2026-09-02 | 356K | 551K | 64.6% | 1,668 |
| 2026-09-01 | 241K | 407K | 59.3% | 2,695 |
| 2026-08-31 | 302K | 390K | 77.3% | 1,901 |
| 2026-08-28 | 219K | 409K | 53.6% | 11,129 |
| 2026-08-27 | 141K | 217K | 65.1% | 900 |
| 2026-08-26 | 278K | 344K | 80.9% | 1,144 |
| 2026-08-25 | 195K | 346K | 56.2% | 0 |
| 2026-08-24 | 415K | 602K | 69.0% | 849 |
| 2026-08-21 | 388K | 684K | 56.7% | 926 |
| 2026-08-20 | 337K | 632K | 53.4% | 2,074 |
| 2026-08-19 | 365K | 528K | 69.3% | 20,743 |
| 2026-08-18 | 313K | 509K | 61.5% | 9,212 |
| 2026-08-17 | 387K | 625K | 62.0% | 393 |
| 2026-08-14 | 481K | 1.1M | 42.8% | 90 |
| 2026-08-13 | 1.0M | 2.0M | 52.3% | 63,496 |
| 2026-08-12 | 1.3M | 1.8M | 72.9% | 25,907 |
| 2026-08-11 | 772K | 1.0M | 76.8% | 1,854 |
| 2026-08-10 | 470K | 708K | 66.4% | 3,350 |
| 2026-08-07 | 162K | 226K | 71.7% | 0 |
| 2026-08-06 | 175K | 224K | 77.9% | 201 |
| 2026-08-05 | 271K | 355K | 76.3% | 0 |
| 2026-08-04 | 305K | 424K | 72.1% | 15,425 |
| 2026-08-03 | 319K | 506K | 63.1% | 1,787 |
| 2026-07-31 | 313K | 406K | 77.1% | 111 |
Fails to deliver
SEC, by settlement date. JSONAs of 12 August 2026, the fails-to-deliver balance in LQDA is 57 shares, down 1,582 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (24 April 2026) to 143,155 shares (20 January 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-12 | 57 | $88.05 | $5K |
| 2026-08-11 | 1,639 | $91.03 | $149K |
| 2026-08-10 | 1,200 | $90.22 | $108K |
| 2026-08-07 | 54 | $89.42 | $5K |
| 2026-08-04 | 11,951 | $83.85 | $1.0M |
| 2026-08-03 | 33 | $84.11 | $3K |
| 2026-07-30 | 2,313 | $86.82 | $201K |
| 2026-07-20 | 6,120 | $79.94 | $489K |
| 2026-07-17 | 92 | $75.27 | $7K |
| 2026-07-07 | 98 | $79.21 | $8K |
| 2026-07-06 | 332 | $78.93 | $26K |
| 2026-06-30 | 43 | $75.12 | $3K |
| 2026-06-29 | 10,882 | $78.17 | $851K |
| 2026-06-25 | 35,657 | $75.54 | $2.7M |
| 2026-06-24 | 116 | $74.04 | $9K |
| 2026-06-23 | 3,000 | $75.49 | $226K |
| 2026-06-22 | 11 | $71.07 | $782 |
| 2026-06-18 | 1 | $68.65 | $69 |
| 2026-06-10 | 1 | $64.01 | $64 |
| 2026-06-09 | 64,338 | $63.90 | $4.1M |
| 2026-06-08 | 1,327 | $61.85 | $82K |
| 2026-06-04 | 4 | $55.69 | $223 |
| 2026-04-24 | 1 | $37.46 | $37 |
| 2026-04-20 | 6,477 | $39.47 | $256K |
| 2026-04-17 | 1,407 | $41.40 | $58K |
| 2026-04-13 | 400 | $38.55 | $15K |
| 2026-04-06 | 581 | $37.68 | $22K |
| 2026-03-23 | 500 | $36.41 | $18K |
| 2026-03-18 | 198 | $36.86 | $7K |
| 2026-03-11 | 3,961 | $38.83 | $154K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at LQDA reported 22 open-market sells worth $53.1M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Krepp Sarah (Chief Human Resource Officer) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Krepp Sarah | Chief Human Resource Officer | Sell | 274 | $67.76 | $19K | 117K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Sell | 42K | $69.09 | $2.9M | 175K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Sell | 32K | $69.09 | $2.2M | 216K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 238 | $14.20 | $3K | 248K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 11K | $14.20 | $153K | 248K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 12K | $9.31 | $110K | 237K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Option exercise | 9K | $9.31 | $84K | 225K |
| 2026-08-20 | Rielly-Gauvin Katherine | n/a | Sell | 18K | $72.23 | $1.3M | 45K |
| 2026-08-20 | Rielly-Gauvin Katherine | n/a | Option exercise | 7K | $2.59 | $17K | 63K |
| 2026-08-20 | Rielly-Gauvin Katherine | n/a | Option exercise | 12K | $2.51 | $29K | 56K |
| 2026-08-19 | Rielly-Gauvin Katherine | n/a | Sell | 37K | $74.99 | $2.8M | 45K |
| 2026-08-19 | Rielly-Gauvin Katherine | n/a | Option exercise | 13K | $2.59 | $35K | 81K |
| 2026-08-19 | Rielly-Gauvin Katherine | n/a | Option exercise | 23K | $2.51 | $59K | 68K |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Sell | 50K | $74.06 | $3.7M | 142K |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Option exercise | 50K | $3.73 | $187K | 192K |
| 2026-08-17 | Saggar Rajeev | Chief Medical Officer | Sell | 30K | $76.84 | $2.3M | 142K |
| 2026-07-27 | Boyle Dana | Chief Accounting Officer | Sell | 2K | $87.53 | $140K | 168K |
| 2026-07-27 | Adair Jason | Chief Business Officer | Sell | 688 | $87.53 | $60K | 216K |
| 2026-07-23 | Bloch Stephen M | n/a | Sell | 4K | $90.71 | $327K | 501K |
| 2026-07-23 | Bloch Stephen M | n/a | Sell | 96K | $89.44 | $8.6M | 505K |
| 2026-07-22 | Bloch Stephen M | n/a | Sell | 15K | $89.24 | $1.3M | 601K |
| 2026-07-22 | Bloch Stephen M | n/a | Sell | 48K | $88.65 | $4.3M | 616K |
| 2026-07-22 | Bloch Stephen M | n/a | Sell | 37K | $87.70 | $3.3M | 664K |
| 2026-07-21 | Bloch Stephen M | n/a | Sell | 556 | $80.66 | $45K | 701K |
| 2026-07-21 | Bloch Stephen M | n/a | Sell | 74K | $79.98 | $6.0M | 702K |
| 2026-07-20 | Bloch Stephen M | n/a | Sell | 4K | $79.55 | $286K | 776K |
| 2026-07-07 | Bloch Stephen M | n/a | Sell | 27K | $81.31 | $2.2M | 780K |
| 2026-07-07 | Bloch Stephen M | n/a | Sell | 23K | $80.48 | $1.8M | 807K |
| 2026-07-06 | Bloch Stephen M | n/a | Sell | 25K | $80.17 | $2.0M | 830K |
| 2026-06-22 | Bloch Stephen M | n/a | Sell | 31K | $76.18 | $2.3M | 880K |
| 2026-06-22 | Bloch Stephen M | n/a | Sell | 70K | $75.54 | $5.3M | 911K |
| 2026-06-09 | Bloch Stephen M | n/a | Sell | 8K | $65.24 | $524K | 1.6M |
| 2026-06-09 | Bloch Stephen M | n/a | Sell | 65K | $64.27 | $4.1M | 1.6M |
| 2026-06-08 | Khindri Sanjeev | Chief Development Officer | Sell | 4K | $65.46 | $271K | 67K |
| 2026-06-08 | Bloch Stephen M | n/a | Sell | 3K | $66.19 | $186K | 1.6M |
| 2026-06-08 | Bloch Stephen M | n/a | Sell | 39K | $65.38 | $2.6M | 1.6M |
| 2026-06-08 | Bloch Stephen M | n/a | Sell | 106K | $64.49 | $6.9M | 1.7M |
| 2026-06-05 | Bloch Stephen M | n/a | Sell | 2K | $64.14 | $132K | 1.8M |
| 2026-06-04 | Manning Paul B | n/a | Sell | 13K | $64.42 | $812K | 798K |
| 2026-06-04 | Manning Paul B | n/a | Sell | 68K | $63.83 | $4.4M | 811K |
| 2026-06-04 | Manning Paul B | n/a | Sell | 19K | $62.62 | $1.2M | 879K |
| 2026-06-04 | Manning Paul B | n/a | Sell | 88K | $64.28 | $5.7M | 716K |
| 2026-06-04 | Manning Paul B | n/a | Sell | 12K | $63.13 | $727K | 805K |
| 2026-06-04 | Bloch Stephen M | n/a | Sell | 1K | $66.08 | $94K | 1.8M |
| 2026-06-04 | Bloch Stephen M | n/a | Sell | 35K | $65.58 | $2.3M | 1.8M |
| 2026-06-04 | Bloch Stephen M | n/a | Sell | 46K | $64.47 | $3.0M | 1.8M |
| 2026-06-03 | KIRSCH ARTHUR S | n/a | Sell | 10K | $54.80 | $548K | 0 |
| 2026-06-02 | KIRSCH ARTHUR S | n/a | Sell | 5K | $56.00 | $280K | 10K |
| 2026-06-01 | Krepp Sarah | Chief Human Resource Officer | Sell | 276 | $60.87 | $17K | 147K |
| 2026-06-01 | KIRSCH ARTHUR S | n/a | Sell | 15K | $60.22 | $903K | 15K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON5 Form 144 notices on file for LQDA worth $15.9M at the prices reported; 5 in the last 90 days worth $15.9M. Latest: RAMANDEEP SINGH filed on 2026-09-11 to sell 9,024 shares ($619K) from 2026-09-11.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-11 | RAMANDEEP SINGHDirector | 9K | $619K | 0.010% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | JASON ADAIROfficer | 74K | $5.2M | 0.082% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | Katherine T. Rielly-GauvinDirector | 55K | $4.1M | 0.062% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | RAJEEV SAGGAROfficer | 50K | $3.7M | 0.056% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | RAJEEV SAGGAROfficer | 30K | $2.3M | 0.033% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON29 holders above 5% have filed on LQDA, all on Schedule 13G (passive). The largest reported stake is Wehrly, Mark C. at 9.4% of the class (8,365,038 shares), filed 2026-08-04 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-04 | 13G/Ano. 3 | Wehrly, Mark C.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dunn Hannah E.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Gehani, Varun N.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Giauque, Nicolasparent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Husen, Avner A.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Kim, David T.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Linn, Michael G.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Luo Patrick (Cheng)parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Roberts, Jr., Thomas G.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Saito Edric C.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Short Daniel S.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Spokes, Andrew J. M.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Warren, John R.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Management, L.L.C.investment adviser, other entity | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dapice Joshua J.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dreyfuss, Philip D.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners III, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Four Crossings Institutional Partners V, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Offshore Investors II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital (AM) Investors, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital F5 Master I, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Healthcare Partners Master, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Partners, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Institutional (GP) V, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon F5 (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Healthcare Partners (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
13F holders
Tracked managers holding LQDA at their latest 13F. JSON6 of the 30 tracked managers held LQDA at their latest 13F, $310.3M in total at quarter-end prices. Citadel Advisors is the largest at $155.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 1.9M | $155.1M | 0.02% | +31K |
| D. E. Shaw & Co. | 2026-06-30 | 1.4M | $108.3M | 0.05% | +449K |
| Two Sigma Investments | 2026-06-30 | 267K | $21.3M | 0.02% | -296K |
| Renaissance Technologies | 2026-06-30 | 232K | $18.5M | 0.03% | +224K |
| AQR Capital Management | 2026-06-30 | 85K | $6.8M | 0.00% | +36K |
| Point72 Asset Management | 2026-06-30 | 3K | $223K | 0.00% | -497K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Liquidia Corp reported revenue of $171.7M, up 1842.7% from the same quarter a year earlier, and net income of $74.7M (0.74 diluted EPS). In FY 2025 it generated -$35.7M of operating cash flow.
- Cash
- $284.2M
- Equity
- $195.1M
- Total assets
- $521.9M
- Shares outstanding
- 89,508,891
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $171.7M | $74.7M | 43.5% | 0.74 |
| Q1 2026 | 2026-03-31 | $132.9M | $52.9M | 39.8% | 0.52 |
| Q4 2025derived | 2025-12-31 | $92.0M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $54.3M | -$3.5M | -6.5% | -0.04 |
| Q2 2025 | 2025-06-30 | $8.8M | -$41.6M | -470.5% | -0.49 |
| Q1 2025 | 2025-03-31 | $3.1M | -$38.4M | -1229.7% | -0.45 |
| Q4 2024 | 2024-12-31 | $2.9M | -$38.5M | -1320.2% | -0.45 |
| Q3 2024 | 2024-09-30 | $4.4M | -$31.0M | -697.6% | -0.40 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $158.3M | n/a | -$35.7M | $4.3M | n/a | n/a |
| FY 2024 | 2024-12-31 | $14.0M | n/a | -$93.4M | $4.9M | n/a | n/a |
| FY 2023 | 2023-12-31 | $17.5M | n/a | -$41.6M | $1.3M | n/a | n/a |
| FY 2022 | 2022-12-31 | $15.9M | n/a | -$28.6M | $592K | n/a | n/a |
| FY 2021 | 2021-12-31 | $12.9M | -$34.6M | -$34.0M | $107K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-29 from the cover page.
What this page is
Liquidia Corp in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Liquidia Corp (LQDA), SEC CIK 1819576, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-12.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-11.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-04.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1819576Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
- UTHRUNITED THERAPEUTICS Corp
- CPIXCUMBERLAND PHARMACEUTICALS INC
- LLYELI LILLY & Co
- ALNYALNYLAM PHARMACEUTICALS, INC.
- PTCTPTC THERAPEUTICS, INC.
- MDGLMADRIGAL PHARMACEUTICALS, INC.
- ONCBeOne Medicines Ltd.
- IONSIONIS PHARMACEUTICALS INC
- INSMINSMED Inc
- CORTCORCEPT THERAPEUTICS INC
- ROIVRoivant Sciences Ltd.
- BBIOBridgeBio Pharma, Inc.
- CYTKCYTOKINETICS INC
- LGNDLIGAND PHARMACEUTICALS INC
- VRTXVERTEX PHARMACEUTICALS INC / MA
- SIONSionna Therapeutics, Inc.
- JAZZJazz Pharmaceuticals plc
- BLTEBELITE BIO, INC
- TVTXTravere Therapeutics, Inc.
- PAHCPHIBRO ANIMAL HEALTH CORP
- ARQTArcutis Biotherapeutics, Inc.
- NATRNATURES SUNSHINE PRODUCTS INC
- HOWLWerewolf Therapeutics, Inc.
- JNJJOHNSON & JOHNSON
Datasets
Frequently Asked Questions
How much of LQDA is sold short?
What is LQDA's daily short volume?
Does LQDA have fails to deliver?
Are LQDA insiders buying or selling?
Have LQDA insiders filed to sell?
Who owns more than 5% of LQDA?
What did LQDA report last quarter?
Which funds hold LQDA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.